Segui
Christopher J A Duncan
Christopher J A Duncan
Email verificata su ncl.ac.uk
Titolo
Citata da
Citata da
Anno
Safety and efficacy of the ChAdOx1 nCoV-19 vaccine (AZD1222) against SARS-CoV-2: an interim analysis of four randomised controlled trials in Brazil, South Africa, and the UK
M Voysey, SAC Clemens, SA Madhi, LY Weckx, PM Folegatti, PK Aley, ...
The Lancet 397 (10269), 99-111, 2021
52212021
Tocilizumab in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial
RECOVERY Collaborative Group
Lancet (London, England) 397 (10285), 1637, 2021
1815*2021
Single-dose administration and the influence of the timing of the booster dose on immunogenicity and efficacy of ChAdOx1 nCoV-19 (AZD1222) vaccine: a pooled analysis of four …
M Voysey, SAC Clemens, SA Madhi, LY Weckx, PM Folegatti, PK Aley, ...
The Lancet 397 (10277), 881-891, 2021
13102021
Clinical features and management of human monkeypox: a retrospective observational study in the UK
H Adler, S Gould, P Hine, LB Snell, W Wong, CF Houlihan, JC Osborne, ...
The Lancet Infectious Diseases 22 (8), 1153-1162, 2022
9882022
COVID-19 vaccine coverage in health-care workers in England and effectiveness of BNT162b2 mRNA vaccine against infection (SIREN): a prospective, multicentre, cohort study
VJ Hall, S Foulkes, A Saei, N Andrews, B Oguti, A Charlett, E Wellington, ...
The Lancet 397 (10286), 1725-1735, 2021
7542021
Efficacy of ChAdOx1 nCoV-19 (AZD1222) vaccine against SARS-CoV-2 variant of concern 202012/01 (B. 1.1. 7): an exploratory analysis of a randomised controlled trial
KRW Emary, T Golubchik, PK Aley, CV Ariani, B Angus, S Bibi, B Blane, ...
The Lancet 397 (10282), 1351-1362, 2021
7292021
SARS-CoV-2 infection rates of antibody-positive compared with antibody-negative health-care workers in England: a large, multicentre, prospective cohort study (SIREN)
VJ Hall, S Foulkes, A Charlett, A Atti, EJM Monk, R Simmons, E Wellington, ...
The Lancet 397 (10283), 1459-1469, 2021
6652021
Single-cell multi-omics analysis of the immune response in COVID-19
E Stephenson, G Reynolds, RA Botting, FJ Calero-Nieto, MD Morgan, ...
Nature medicine 27 (5), 904-916, 2021
4782021
Casirivimab and imdevimab in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial
RECOVERY Collaborative Group, PW Horby, M Mafham, L Peto, ...
Medrxiv, 2021.06. 15.21258542, 2021
436*2021
First experience of COVID-19 screening of health-care workers in England
E Hunter, DA Price, E Murphy, IS van der Loeff, KF Baker, D Lendrem, ...
The Lancet 395 (10234), e77-e78, 2020
3722020
Protective CD8+ T-cell immunity to human malaria induced by chimpanzee adenovirus-MVA immunisation
KJ Ewer, GA O’Hara, CJA Duncan, KA Collins, SH Sheehy, ...
Nature communications 4 (1), 2836, 2013
3492013
Preliminary assessment of the efficacy of a t-cell–based influenza vaccine, MVA-NP+ M1, in humans
PJ Lillie, TK Berthoud, TJ Powell, T Lambe, C Mullarkey, AJ Spencer, ...
Clinical infectious diseases 55 (1), 19-25, 2012
2892012
Reactogenicity and immunogenicity after a late second dose or a third dose of ChAdOx1 nCoV-19 in the UK: a substudy of two randomised controlled trials (COV001 and COV002)
A Flaxman, NG Marchevsky, D Jenkin, J Aboagye, PK Aley, B Angus, ...
The Lancet 398 (10304), 981-990, 2021
2682021
Immunogenicity of standard and extended dosing intervals of BNT162b2 mRNA vaccine
RP Payne, S Longet, JA Austin, DT Skelly, W Dejnirattisai, S Adele, ...
Cell 184 (23), 5699-5714. e11, 2021
2642021
COVID-19-associated hyperinflammation and escalation of patient care: a retrospective longitudinal cohort study
JJ Manson, C Crooks, M Naja, A Ledlie, B Goulden, T Liddle, E Khan, ...
The Lancet Rheumatology 2 (10), e594-e602, 2020
2612020
Clinical assessment of a recombinant simian adenovirus ChAd63: a potent new vaccine vector
GA O’Hara, CJA Duncan, KJ Ewer, KA Collins, SC Elias, FD Halstead, ...
Journal of Infectious Diseases 205 (5), 772-781, 2012
2512012
ChAd63-MVA–vectored blood-stage malaria vaccines targeting MSP1 and AMA1: assessment of efficacy against mosquito bite challenge in humans
SH Sheehy, CJA Duncan, SC Elias, P Choudhary, S Biswas, FD Halstead, ...
Molecular Therapy 20 (12), 2355-2368, 2012
2442012
Novel coronavirus disease (Covid-19): the first two patients in the UK with person to person transmission
PJ Lillie, A Samson, A Li, K Adams, R Capstick, GD Barlow, N Easom, ...
Journal of Infection 80 (5), 578-606, 2020
2302020
Aspirin in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial
RECOVERY Collaborative Group
Lancet (London, England) 399 (10320), 143, 2022
2262022
Human IFNAR2 deficiency: Lessons for antiviral immunity
CJA Duncan, SMB Mohamad, DF Young, AJ Skelton, TR Leahy, ...
Science translational medicine 7 (307), 307ra154-307ra154, 2015
2232015
Il sistema al momento non può eseguire l'operazione. Riprova più tardi.
Articoli 1–20